BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:We are happy to announce that the Mitochondria-Targeted Drug D
 evelopment Summit\, focused on the pursuit for novel effective therapies 
 for mitochondrial disorders/dysfunction\, return for its 2nd edition.\n\n
 Incorporating insights from leading academics and pioneering biotech\, th
 is forum will specifically focus on targeting mitochondrial dysfunction t
 o develop therapies for chronic diseases caused by mitochondrial DNA muta
 tion/nuclear DNA mutations\, muscle dystrophy diseases/muscle loss\, meta
 bolic disorders\, neurodegenerative disease\, and conditions linked to ox
 idative damage.\n\nFrom basic research to the clinic\, this year’s meetin
 g will examine novel preclinical animal modelling solutions specifically 
 targeting mitochondria\, deliver an update on the current leading clinica
 l trials showcasing mitochondrial transfer\, mutations\, metabolism\, qua
 lity control\, biogenesis\, and peroxidation/ oxidation\, along with dedi
 cated sessions on the significance on informatics and data sharing for pr
 ecision medicine.\n\nJoin 80+ leading experts as they navigate common cha
 llenges and opportunities for treating unmet medical needs caused by mito
 chondrial dysfunction. Mitobridge/Astellas\, Minovia Therapeutics\, Abliv
 a\, GenSight Biologics\, Stealth Biotherapeutics and many more will unite
  drive to better understand how to create effective and scalable mitochon
 drial therapies.\n
DTEND:20220224T170000
DTSTAMP:20260512T214259Z
DTSTART:20220222T090000
LOCATION:Online\, \,
SEQUENCE:0
SUMMARY:We are happy to announce that the Mitochondria-Targeted Drug Devel
 opment Summit\, focused on the pursuit for novel effective therapies for 
 mitochond...
UID:1bf9e0b1-7f01-451e-bf1f-ca8c13978828
END:VEVENT
END:VCALENDAR